Stock·NYSE·Industrials
Trane Technologies (TT)
- Market cap
- $100.97B
- P/E
- 34.08
- Dividend yield
- 0.89%
- Street target
- $534.00median of 25 analysts
- 52-week range
- $348.06 $505.87
The short version
Where TT stands today, in four lines, and what CleaRank Financial AI makes of it.
TT at a glance
Trane Technologies (TT): Buy, 65/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($455.07 and $451.68).
- Earnings TT beat estimates in 8 of its last 8 quarters, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $67.0M and bought $172K over the last 18 months.
- Valuation P/E of 34.1 against 34.0 for the Industrials sector: broadly in line with peers (+0%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Trane Technologies (TT) Buy, with a model score of 65/100.
The analysts' outlook lifts the score most: 15 of 25 analysts rate it a buy and the median target is 16.4% above the price. The trend is up: TT trades 0.84% above its 50-day average of $455.07 and 1.60% above its 200-day average of $451.68. Over the past year the price rose 10.33%.
Only on CleaRank
Figures we compute ourselves from TT's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $458.89 is 0.8% above the 50-day simple moving average of $455.07.Price above its 200-day average ›
The price is 1.6% above the 200-day simple moving average of $451.68.50-day average above the 200-day ›
The 50-day average ($455.07) is 0.7% above the 200-day average ($451.68), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 70% of its 52-week range, between $348.06 and $505.87.
TT share price
Pick a period: each tab shows how far TT has moved over it, to the last close.
Today's trading
Where TT sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 34.08 is 0.2% above the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 4.53 is 13.3% above the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $3.0B on revenue of $22.2B, a net margin of 13.5%.Beat estimates in most recent reports ›
TT beat the EPS estimate in 8 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 0.89%, or $4.09 a share a year.
Key statistics
The headline figures for TT.
As of October 17, 2026, TT trades at $458.89, with a market value of $100.97B, a P/E ratio of 34.08 and a dividend yield of 0.89%.
What the numbers say
CleaRank Financial AI's reading of TT's valuation, growth and risks.
TT's trailing P/E stands at 34.08, set against an Industrials median of 34.0; that places it 0.2% above the median, and the peer comparison on this page calls it broadly in line with peers. Its price-to-sales ratio of 4.53 is 13.3% above the sector median of 4.0. To put the multiples in context, trailing earnings per share are $13.42.
TT is growing more slowly than its peers: revenue rose 10.60% in the latest year, while the sector median is 11.7%. On profitability, the net margin stands at 13.28% and the operating margin at 19.25%. Return on equity of 36.64% is above the sector median of 17.8%. Finally, debt-to-equity is 0.53, and the trailing dividend yield is 0.89%, which works out to $4.09 a share each year.
On July 30, 2026, TT reported earnings that beat the estimate by 1.17%: EPS came in at $4.31, compared with the $4.26 analysts had forecast. Investors responded positively, and the stock rose 3.33% in the following session.
The record is a clean sweep: 8 beats in 8 reports, but beats have not guaranteed gains: the stock fell the next day after 4 of them. Looking ahead, analysts expect EPS of $15.26 this fiscal year (growth of 16.9%) and $17.59 the year after (growth of 15.3%).
Day-to-day price swings are the main thing to keep in mind with TT, which has moved 1.43% on an average session. Over the last 18 months, insiders sold $67.0M of stock and bought $172K. Insider sales are often planned ahead or made to cover taxes on vesting shares, so they tell less than open-market purchases would.
TT against the Industrials sector
How TT compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (0% difference), suggesting fair market pricing relative to industry standards.
Return vs XLI: Since May 6, 2025, TT has gained 12.8% against a gain of 25.7% for XLI.
Performance against XLI
TT and the Industrials sector fund over the same days.
Revenue and earnings
How much TT sells, and how much of it becomes profit.
Revenue growth: Revenue grew 7.5% in FY2025 to $21.3B, from $19.8B a year earlier.
Profit margin: The net margin was 13.8% in FY2025, up from 13.1% the year before.
Profitable: TT earned $2.9B in FY2025.
Earnings reality check
Did TT beat what analysts expected, and how did the stock react?
Earnings record: TT beat the analyst estimate in 8 of the last 8 quarters.
Market reaction: The stock fell in the first session after 4 of those 8 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 30, 2026after close | $4.26 | $4.31 | +1.17% | +3.33% | +8.72% |
| Apr 30, 2026after close | $2.53 | $2.63 | +3.95% | -1.23% | -4.61% |
| Jan 29, 2026after close | $2.81 | $2.86 | +1.78% | -1.29% | +2.37% |
| Oct 30, 2025after close | $3.78 | $3.88 | +2.65% | +0.51% | -2.41% |
| Jul 30, 2025after close | $3.79 | $3.88 | +2.37% | +1.54% | -1.02% |
| Apr 30, 2025after close | $2.20 | $2.45 | +11.36% | +2.43% | +6.24% |
| Jan 30, 2025after close | $2.54 | $2.61 | +2.76% | -0.97% | -2.35% |
| Oct 30, 2024after close | $3.24 | $3.37 | +4.01% | -1.43% | +4.35% |
As of October 17, 2026, TT has beaten the analyst EPS estimate in 8 of its last 8 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on July 30, 2026, came in 1.17% above the estimate and the stock moved +3.33% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 49.7, in neutral territory.RSI above 50 ›
An RSI of 49.7 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of TT
The score, the reasoning behind it, and what could move the price next.
Trane Technologies (TT) is in an uptrend: the price of $458.89 sits 1.60% above its 200-day average of $451.68 and 0.84% above its 50-day average of $455.07. Trading near the top of its 52-week range, the stock is 9.29% below its high of $505.87 and 31.84% above its low of $348.06. The 50-day average is 0.75% above the 200-day, so the two averages are arranged in the same upward order.
Short-term and long-term price action disagree. Over the past month the price climbed 8.82%, yet it slid 2.36% across the past three months and gained 10.33% over the past year. Momentum sits in the neutral zone with a 14-day RSI of 49.7, while the MACD line is positive.
Earnings beat ›
The July 30, 2026 report beat the EPS estimate by 1.17%, and the share price rose 3.33% in the first session after it.
Source: Earnings report, July 30, 2026Rating reaffirmed ›
JP Morgan kept its Overweight rating on October 9, 2026.
Source: Analyst action, JP Morgan, October 9, 2026
New analyst coverage ›
Wells Fargo started coverage at Overweight on September 25, 2026.
Source: Analyst action, Wells Fargo, September 25, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $461.23 sits above the price, and the 50-day SMA at $455.07 sits below it.
- The 14-day RSI reads 49.7, in the neutral zone, with the MACD line positive; readings above 70 or below 30 mark stretched momentum.
- In the first session after the July 30, 2026 report, the share price rose 3.33%. TT has beaten estimates in 8 of the last 8 reports.
TT's uptrend depends on the price holding above its 50-day average of $455.07 and its 200-day average of $451.68. A close below the 50-day average would be the first sign of weakness. If the price pulls back, the 50-day SMA at $455.07 is the first level it would reach.
Looking up, the first level the price would meet is the 20-day EMA, at $461.23.
Technical indicators
Momentum and trend for TT, from its daily closes.
As of October 17, 2026, with TT at $458.89, its 14-day RSI is 49.7 (neutral territory), its 50-day simple moving average is $455.07 and its 200-day is $451.68.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What TT moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, TT's 1-year correlation of daily returns is +0.58 with S&P 500 (SPY), +0.55 with Nasdaq 100 (QQQ), +0.15 with Bitcoin (BTC) and +0.16 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
15 of 25 analysts rate it a buy or strong buy, 10 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $534.00 is 16.4% above the price.More buy ratings than three months ago ›
15 of 25 rate it a buy now, against 13 of 24 three months ago.
TT Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | JP Morgan | Reinstates | Overweight |
| Sep 25, 2026 | Wells Fargo | Initiates | Overweight |
| Aug 14, 2026 | Bernstein | Maintains | Outperform |
| Jul 31, 2026 | RBC Capital | Maintains | Sector Perform |
| Jul 31, 2026 | Citigroup | Maintains | Buy |
| May 14, 2026 | JP Morgan | Maintains | Neutral |
As of October 17, 2026, 25 Wall Street analysts cover TT: 15 rate it a buy or strong buy, 10 a hold and 0 a sell or strong sell. Their 12-month price targets range from $422.00 to $575.00, with a median of $534.00, 16.4% above the price of $458.89.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
TT trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from TT's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much TT tends to move, against the market and on its own.
The long record
TT's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.43% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 36.2%, from December 2021 to June 2022, regained by July 2023.Most 1-year holds ended higher ›
85% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $105,530, against $42,055 in the S&P 500 (SPY).
TT Drawdowns & Recovery
As of October 17, 2026, TT's worst peak-to-trough fall over the last 10 years with dividends reinvested was -36.2% (December 2021 to June 2022); it regained that peak by July 2023, 13 months after the low, and 85% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into TT in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: TT beat the S&P 500 over this period: $105,530 against $42,055.
A $10,000 investment in TT in October 2016 would be worth about $105,530 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to TT, and which have not.
Strongest month, November: an average of +6.97%, up in 8 of 10 years.
Weakest month, March: an average of -1.40%, up in 5 of 10 years.
This month, October: has averaged +1.15%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, TT's strongest calendar month has been November (average +6.97%, up in 8 of 10 years) and its weakest March (average -1.40%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in TT, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in TT today could grow to about $28,059 by 2036 in the base case, with a 90th-percentile outcome near $85,449 and a 10th-percentile outcome around $9,213. The simulation models price only; at today's 0.89% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
TT Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $693 for TT by 2030 in the base case, from $459 today (1.5x over 4 years). The 10th-percentile path ends near $343. These are outcomes of a Monte Carlo simulation run on TT's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $358 | $509 | $724 | |
| 2028 | $343 | $564 | $928 | |
| 2029 | $340 | $625 | $1,151 | |
| 2030 | $343 | $693 | $1,402 | |
| 2031 | $350 | $769 | $1,689 |
Method: a lognormal simulation of TT's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
TT insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $172K on the open market and sold $67.0M.
As of October 17, 2026, TT insiders reported 20 open-market sales worth $67.0M and 1 open-market purchase worth $172K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | David S Regnery
Chief Executive Officer
|
Sell | 43.8K | $20.8M |
| Aug 5, 2026 | David S Regnery
Chief Executive Officer
|
Option | 43.8K | $3.1M |
| Aug 4, 2026 | Melissa N Schaeffer
Director
|
Sell | 145 | $68.5K |
| Jul 1, 2026 | Donald E Simmons
Chief Operating Officer
|
Grant | 826 | - |
| Jun 5, 2026 | Kirk E Arnold
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Ann C Berzin
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Jesus Assis Ana Paula De
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Mark R. George
Director
|
Grant | 438 | - |
| Jun 5, 2026 | John A Hayes
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Myles P Lee
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Boise April Miller
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Matthew Francis Pine
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Melissa N Schaeffer
Director
|
Grant | 438 | - |
| Jun 5, 2026 | John P Surma Jr.
Director
|
Grant | 438 | - |
| Apr 30, 2026 | Donald E Simmons
Officer
|
Sell | 4.6K | $2.3M |
| Apr 30, 2026 | Donald E Simmons
Officer
|
Option | 4.6K | $828.8K |
| Apr 8, 2026 | Christopher J Kuehn
Chief Financial Officer
|
Sell | 8.6K | $3.9M |
| Mar 6, 2026 | David S Regnery
Chief Executive Officer
|
Sell | 36.0K | $15.2M |
| Mar 6, 2026 | Donald E Simmons
Officer
|
Sell | 3.8K | $1.6M |
| Mar 6, 2026 | Elizabeth A Elwell
Officer
|
Sell | 635 | $268.4K |
| Mar 5, 2026 | John A Hayes
Director
|
Buy | 400 | $172.2K |
| Mar 4, 2026 | Elizabeth A Elwell
Officer
|
Grant | 888 | - |
| Mar 4, 2026 | Christopher J Kuehn
Chief Financial Officer
|
Grant | 15.2K | - |
| Mar 4, 2026 | Mairead Magner
Officer
|
Grant | 4.3K | - |
| Mar 4, 2026 | David S Regnery
Chief Executive Officer
|
Grant | 63.7K | - |
| Mar 4, 2026 | Donald E Simmons
Officer
|
Grant | 6.7K | - |
| Feb 12, 2026 | Donald E Simmons
Officer
|
Sell | 7.7K | $3.6M |
| Feb 12, 2026 | Donald E Simmons
Officer
|
Option | 7.7K | $1.3M |
| Feb 10, 2026 | David S Regnery
Chief Executive Officer
|
Sell | 5.6K | $2.6M |
| Feb 10, 2026 | Christopher J Kuehn
Chief Financial Officer
|
Sell | 2.4K | $1.1M |
| Feb 10, 2026 | Donald E Simmons
Officer
|
Sell | 822 | $380.2K |
| Feb 10, 2026 | Elizabeth A Elwell
Officer
|
Sell | 137 | $63.4K |
| Feb 6, 2026 | David S Regnery
Chief Executive Officer
|
Sell | 987 | $445.2K |
| Feb 6, 2026 | Donald E Simmons
Officer
|
Sell | 439 | $198.1K |
| Feb 6, 2026 | Elizabeth A Elwell
Officer
|
Sell | 46 | $20.8K |
| Feb 3, 2026 | Mauro Atalla
Officer
|
Grant | 977 | - |
| Feb 3, 2026 | Elizabeth A Elwell
Officer
|
Grant | 230 | - |
| Feb 3, 2026 | Mingxiao Gary Guo
Officer
|
Grant | 919 | - |
| Feb 3, 2026 | Christopher J Kuehn
Chief Financial Officer
|
Grant | 2.7K | - |
| Feb 3, 2026 | Victoria Viviane Lazar
Officer
|
Grant | 919 | - |
| Feb 3, 2026 | Mairead Magner
Officer
|
Grant | 862 | - |
| Feb 3, 2026 | David S Regnery
Chief Executive Officer
|
Grant | 8.3K | - |
| Feb 3, 2026 | Donald E Simmons
Officer
|
Grant | 2.0K | - |
| Dec 4, 2025 | Mingxiao Gary Guo
Officer
|
Grant | 5.9K | - |
| Oct 30, 2025 | Elizabeth A Elwell
Officer
|
Sell | 600 | $264.0K |
| Oct 30, 2025 | Elizabeth A Elwell
Officer
|
Option | 600 | $47.4K |
| Oct 1, 2025 | Elizabeth A Elwell
Officer
|
Sell | 401 | $170.4K |
| Oct 1, 2025 | Elizabeth A Elwell
Officer
|
Option | 401 | $28.2K |
| Sep 2, 2025 | David S Regnery
Chief Executive Officer
|
Sell | 22.5K | $9.2M |
| Sep 2, 2025 | David S Regnery
Chief Executive Officer
|
Option | 22.5K | $1.4M |
| Aug 20, 2025 | Christopher J Kuehn
Chief Financial Officer
|
Grant | 300 | - |
| Jun 5, 2025 | Kirk E Arnold
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Ann C Berzin
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Jesus Assis Ana Paula De
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Mark R. George
Director
|
Grant | 465 | - |
| Jun 5, 2025 | John A Hayes
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Linda P Hudson
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Myles P Lee
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Boise April Miller
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Matthew Francis Pine
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Melissa N Schaeffer
Director
|
Grant | 465 | - |
| Jun 5, 2025 | John P Surma Jr.
Director
|
Grant | 465 | - |
| May 2, 2025 | Donald E Simmons
Officer
|
Sell | 8.4K | $3.4M |
| May 2, 2025 | Donald E Simmons
Officer
|
Option | 8.4K | $1.3M |
| Apr 30, 2025 | Donald E Simmons
Officer
|
Sell | 3.6K | $1.4M |
| Apr 30, 2025 | Donald E Simmons
Officer
|
Option | 3.6K | $376.0K |
Source: TwelveData, from reported insider filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.